510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K051925Substantially Equivalent

Carestart Cardiac 3-in-1 Troponin 1/Ck-Mb/myoglobin

Access Bio Incorporate, Monmouth Jct. NJ / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K051925 is the FDA 510(k) clearance record for CARESTART CARDIAC 3-IN-1 TROPONIN 1/CK-MB/MYOGLOBIN, a class II device, cleared for Access Bio Incorporate on under FDA product code MMI (Immunoassay Method, Troponin Subunit). FDA records list 4 510(k) clearances for Access Bio Incorporate, from to . As of , FDA records show no recalls naming K051925.

Clearance record

Decision date
Received
(134 days to decision)
Product code
MMI Immunoassay Method, Troponin Subunit
Regulation
21 CFR 862.1215
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Access Bio Incorporate 2033 Rt. 130 Unit H, Monmouth Jct. NJ
510(k) summary
Statement
Third party review
No

Clearances, product code MMI

Trailing 12 months
1 clearance under product code MMI in the twelve months to October 2026, June 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code MMI, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20261
July 20260
August 20260
September 20260
October 20260